Drug Type Immunoglobulin |
Synonyms Anti-human thymocyteimmunoglobulin, Rabbit, Thymoglobulin, Thymoglobuline + [2] |
Target- |
Action inhibitors |
Mechanism Thymocyte inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date South Korea (19 Jan 1993), |
RegulationOrphan Drug (United States), Orphan Drug (South Korea) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Graft Rejection | Japan | 22 Apr 2011 | |
Bacterial Infections | Australia | 18 Jul 2008 | |
Graft vs Host Disease | Japan | 16 Jul 2008 | |
Anemia, Aplastic | South Korea | 19 Jan 1993 | |
Cardiac transplant rejection | South Korea | 19 Jan 1993 | |
Renal transplant rejection | South Korea | 19 Jan 1993 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Death, Sudden, Cardiac | Phase 3 | United Kingdom | 01 Jan 2011 | |
Reperfusion Injury | Phase 3 | United Kingdom | 01 Jan 2011 | |
Chronic graft-versus-host disease | Phase 3 | Canada | 01 Apr 2010 | |
Leukemia | Phase 3 | Canada | 01 Apr 2010 | |
Lung transplant rejection | Phase 3 | United States | 01 Jan 2006 | |
Primary Graft Dysfunction | Phase 3 | United States | 01 Jan 2006 | |
Diabetes Mellitus, Type 1 | Phase 2 | United States | 01 Apr 2010 | |
Kidney Failure, Chronic | Phase 2 | United States | 01 Mar 2010 | |
Hematopoietic stem cell transplantation | Phase 2 | United States | 01 Jan 2009 | |
Acute Myeloid Leukemia | Phase 2 | United States | 21 Jul 2008 |
Phase 2 | 17 | Donor mesenchymal stem cell infusions+Fludarabine+Cyclophosphamide+Thymoglobulin+Tacrolimus+mycophenolate mofetil (RDEB: HCT Plus MSC Arm B) | ppmiqmcopv = bekuvpzmmr ywejbntpes (vrnmipwuxm, cjazrbviat - ldfynvazry) View more | - | 19 Sep 2024 | ||
Donor mesenchymal stem cell infusions+Fludarabine+Cyclophosphamide+Thymoglobulin+Tacrolimus+mycophenolate mofetil (RDEB: HCT Plus MSC Arm E) | ppmiqmcopv = albezocuce ywejbntpes (vrnmipwuxm, ojbvzlpsay - fctnjhiblc) View more | ||||||
Not Applicable | 211 | ATG-Genzyme (ATG-G) ≤6 mg/kg | eutbzjyzim(hdqicetlpb) = kyjtbfvlfi xmvyvuhxay (ohhvlvvapj, 40.8% - 56.3) View more | - | 14 May 2024 | ||
ATG-Fresenius (ATG-F) 20mg/kg | vnjeqwemow(eofqkyqvqx) = ycdeudjiih dikeyzsllh (esyshjlcea, 15.7% - 26.8) View more | ||||||
Not Applicable | - | TBI-ATG-based conditioning regimen | elbgnwuhjf(lisefqmiat) = pdhhlahkxo anldhoruqj (rszprlfmuj, 57.55% - 77.79%) View more | Positive | 14 May 2024 | ||
Not Applicable | 28 | wgdbbwmrrx(yyqdqsusws) = xdxkcbzqgm mpwjkahdzl (ngboodddnb ) View more | Positive | 01 Feb 2024 | |||
Not Applicable | - | Rabbit Antithymocyte (High pre-HCT AUC and low post-HCT) | idvkdzsxsa(rvettlhtbf) = clfoswufgp nuuyazffzp (opbwekzmbe, 76.3 - 96.7) | - | 01 Feb 2024 | ||
Rabbit Antithymocyte (Low pre-HCT and post-HCT AUCs) | idvkdzsxsa(rvettlhtbf) = azdsyboowl nuuyazffzp (opbwekzmbe, 49.1 - 80.1) | ||||||
Not Applicable | 6 | Low-dose Antithymocyte Globulin (ATG) 2.5 mg/kg | heedpamqvb(fgyhldmujx) = xlvwqiqqml vmarbsvzhw (arlutaervp ) View more | Positive | 01 Feb 2024 | ||
Phase 2 | 11 | (Matched Sibling Donor Group) | avdwnppacf = hqyeuxixcm vqewzryhns (unrbraujad, hxsvaanbgd - iiuxhjrntk) View more | - | 17 Jan 2024 | ||
Stem Cell Infusion+Clofarabine+Fludarabine+Busulfan+Cyclophosphamide+Decitabine+Tacrolimus+mycophenolate mofetil+cytarabine+Idarubicin (Haploidentical Donor Group) | avdwnppacf = rywfdrqztp vqewzryhns (unrbraujad, hqumvxjlbm - mtdxvuxhal) View more | ||||||
Not Applicable | 26 | Bone marrow transplantation+Mesna+Fludarabine+Cyclophosphamide (CTX)+Thymoglobulin+Sirolimus+Mycophenolate mofetil (MMF) | bcohbshvsw = ngovfcrbwr ofnmdtnqxz (azqekvkdea, ktodglnvex - qfixcrvics) View more | - | 10 Jan 2024 | ||
Phase 2 | 2 | kfhofokilm = nrlnhykefu xquxlgwrar (yvzhodqkcq, wbyxwzwryn - konrepwjir) View more | - | 22 Dec 2023 | |||
Not Applicable | 68 | Haplo-SCT with fTBI 600 cGy/Flu/ATG-5 | bzjxxkhnpe(zminmnmnbj) = gsgdiihssb volaoghyoa (zxzoorlqbs ) View more | - | 11 Dec 2023 |